Cendakimab is safe and efficacious in treating moderate-to-severe AD in adult patients.

On Aug. 14, World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus declared that the upsurge of the infectious...

Patients with moderate-to-severe PsO are more than twice as likely to take a half-day off work than those with mild psoriasis

The widespread use of Ozempic (semaglutide) for weight loss has significantly impacted cosmetic dermatology, according to Dr. Zaki Taher...

Last year's recipients of the Canadian Skin of Colour Diversity Scholarship award discuss their projects and reasons to apply.

Pioneering dermatologist Dr. Alastair Carruthers, co-discoverer of the cosmetic applications of botulinum toxin A, has died. A tribute ...

White rosacea patients have an increased risk for malignant melanoma than non-White patients.

Researchers at Binghamton University, State University of New York, have identified an innovative wound care approach that merges...